Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Moolec Science S.A. (MLEC:NASDAQ), powered by AI.
Moolec Science S.A. is currently trading at $7.86. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Moolec Science S.A. on Alpha Lenz.
Moolec Science S.A.'s P/E ratio is -0.0.
“Moolec Science S.A. trades at a P/E of -0.0 (undervalued) with strong ROE of 344.2%.”
Ask for details →Moolec Science S.A. is a forward-thinking biotechnology company focused on revolutionizing the agri-food sector through molecular farming techniques. Primarily, Moolec aims to blend plant and animal biology to produce animal proteins using plant-based systems, offering an innovative solution to traditional livestock farming. These proteins are developed to retain the nutritional value and taste profile of animal-derived proteins, targeting application in the food industry to cater to growing demands for sustainable and ethical food options. The company operates at the intersection of agriculture and biology, impacting industries that prioritize environmental sustainability and efficient food production processes. By using plants as bioreactors, Moolec Science strives to offer scalable and climate-friendly alternatives to conventional protein sources. The company's technology holds potential significance in reducing the environmental footprint of protein production, which is increasingly gaining importance in global sustainability agendas. Moolec Science S.A.’s efforts contribute to the broader biotech landscape by enabling cleaner production methods in alignment with global agricultural and nutritional trends.
“Moolec Science S.A. trades at a P/E of -0.0 (undervalued) with strong ROE of 344.2%.”
Ask for details →Moolec Science S.A. (ticker: MLEC) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 52 employees. Market cap is $3M.
The current price is $7.86 with a P/E ratio of -0.03x and P/B of -0.05x.
ROE is 344.24% and operating margin is -1.05%. Annual revenue is $334M.